Comparative performances of the new chronic kidney disease epidemiology equations incorporating cystatin C for use in cancer patients

Asia-Pacific Journal of Clinical Oncology

Volumn 11, Issue 2, 2015, Pages 142-151

  Chew Harris, Janice S C ^a,b   Florkowski, Christopher M ^a,b   George, Peter M ^a,b   Endre, Zoltan H ^b,c  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Creatinine; Cystatin C; Glomerular filtration rate

Indexed keywords

CREATININE; CYSTATIN C; PENTETATE TECHNETIUM TC 99M;

ADULT; ARTICLE; CANCER PATIENT; CHRONIC KIDNEY DISEASE; COCKCROFT GAULT EQUATION; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DONOR; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL PARAMETERS; MEASUREMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BLOOD; MIDDLE AGED; NEOPLASMS; RENAL INSUFFICIENCY, CHRONIC;

ADULT; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84928824319     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12312     Document Type: Article

References (47)

1. Newman DJ. Cystatin C. Ann Clin Biochem 2002; 39 (2): 89-104.
2. Tenstad O, Roald A, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 1996; 56 (5): 409-414.
3. Sjöström P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 2005; 65 (2): 111-124.
4. Newman DJ, Thakkar H, Edwards RG etal. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47 (1): 312-318.
5. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40 (2): 221-226.
6. Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children - a meta-analysis. Clin Biochem 2007; 40 (5): 383-391.
7. Chew JS, Saleem M, Florkowski CM, George PM. Cystatin C - a paradigm of evidence based laboratory medicine. Clin Biochem Rev 2008; 29 (2): 47-62.
8. Lamb EJ, Levey AS, Stevens PE. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution. Clin Chem 2013; 59 (3): 462-465.
9. KDIGOKCW Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2013; 3 (1): 1-150.
10. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38 (10): 1933-1953.
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130 (6): 461-470.
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 31-41.
13. Levey AS, Coresh J, Greene T etal. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53 (4): 766-772.
14. Levey AS, Stevens LA, Schmid CH etal. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150 (9): 604-612.
15. Saleem M, Florkowski CM, George PM, Woltersdorf WW. Comparison of two prediction equations with radionuclide glomerular filtration rate: validation in routine use. Ann Clin Biochem 2006; 43 (Pt 4): 309-313.
16. Barraclough LH, Field C, Wieringa G, Swindell R, Livsey JE, Davidson SE. Estimation of renal function - what is appropriate in cancer patients? Clin Oncol 2008; 20 (10): 721-726.
17. Chew JS, Saleem M, Florkowski CM, George PM. Estimating renal function in oncology patients using cystatin C-based equations. Clin Oncol 2009; 21 (5): 425-426.
18. Stevens LA, Coresh J, Schmid CH etal. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis 2008; 51 (3): 395-406.
19. Inker LA, Schmid CH, Tighiouart H etal. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367 (1): 20-29.
20. Shlipak MG, Matsushita K, Ärnlöv J etal. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013; 369 (10): 932-943.
21. Du Bois D, Du Bois EF. Clinical calorimetry: tenth paper a formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17 (6_2): 863-871.
22. SIEMENS Dade Behring GmBH (Marburg). N-Latex Cystatin C package insert. OQNM G13 E1401 (1215). 2012. pp. 1-6.
23. Abbott Laboratories. MULTIGENT creatinine enzymatic package insert. 8L24. 2013. pp. 1-8.
24. Piéroni L, Delanaye P, Boutten A etal. A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clin Chim Acta 2011; 412 (23): 2070-2075.
25. Abbott Laboratories. Creatinine. Package insert. REF 3L81 304747/R02. 2012. pp. 1-8.
26. Johnson DW, Jones GR, Mathew TH etal. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations. Med J Aust 2012; 197 (4): 224-225.
27. Hollis S. Analysis of method comparison studies. Ann Clin Biochem 1996; 33: 1-4.
28. Calvert A, Newell D, Gumbrell L etal. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 7 (11): 1748-1756.
29. Dooley M, Poole S, Rischin D. Dosing of cytotoxic chemotherapy: impact of renal function estimates on dose. Ann Oncol 2013; 24 (11): 2746-2752.
30. Launay-Vacher V, Izzedine H, Rey J-B etal. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients. Med Sci Monit 2004; 10 (5): CR209.
31. Launay-Vacher V, Oudard S, Janus N etal. Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management. Cancer 2007; 110 (6): 1376-1384.
32. Séronie-Vivien S, Toullec S, Malard L, Thomas F, Durrand V, Chatelut E. Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patients. Med Oncol 2006; 23 (1): 63-73.
33. Kos J, Štabuc B, Cimerman N, Brünner N. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem 1998; 44 (12): 2556-2557.
34. Štabuc B, Vrhovec L, Štabuc-Šilih M, Cizej TE. Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clin Chem 2000; 46 (2): 193-197.
35. Marx G, Blake G, Galani E etal. Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Ann Oncol 2004; 15 (2): 291-295.
36. Ainsworth N, Marshall A, Hatcher H, Whitehead L, Whitfield G, Earl H. Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients. Ann Oncol 2012; 23 (7): 1845-1853.
37. Mathew TH, Johnson DW, Jones GR, Australasian Creatinine Consensus Working Group. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 2007; 187 (8): 459-463.
38. Boutten A, Bargnoux A-S, Carlier M-C etal. Enzymatic but not compensated Jaffe methods reach the desirable specifications of NKDEP at normal levels of creatinine. Results of the French multicentric evaluation. Clin Chim Acta 2011; 412: 2070-2075.
39. Levey AS, Atkins R, Coresh J etal. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease: Improving Global Outcomes. Kidney Int 2007; 72: 247-259.
40. National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. [Cited Jan 2014.]. Available from URL: http://www.kidney.org/professionals/kdoqi/guidelines.cfm
41. Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K. Estimating equations for glomerular filtration rate in the era of creatinine standardization: A systematic review. Ann Intern Med 2012; 156 (11): 785-795.
42. Kuster N, Cristol J-P, Cavalier E etal. Enzymatic creatinine assays allow estimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation. Clin Chim Acta 2014; 428: 89-95.
43. Jones GR. Estimating renal function for drug dosing decisions. Clin Biochem Rev 2011; 32 (2): 81-88.
44. Terpos E, Christoulas D, Kastritis E etal. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations? Eur J Haematol 2013; 91 (4): 347-355.
45. Rogacev KS, Pickering JW, Seiler S etal. The CKD-EPI equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease. Nephrol Dial Transplant 2014; 29: 348-355.
46. Chew-Harris JS, Florkowski CM, George PM, Elmslie JL, Endre ZH. The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men. Ann Clin Biochem 2013; 50 (Pt 1): 39-46.
47. Rule AD, Bailey KR, Lieske JC, Peyser PA, Turner ST. Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 2013; 83: 1169-1176.